Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:17 PM
Ignite Modification Date:
2025-12-24 @ 3:17 PM
NCT ID:
NCT02872792
Eligibility Criteria:
Inclusion Criteria:
* Patient hospitalized in ICU
* Septic shock diagnosed more than 24 hours before inclusion
* Patient hemodynamically stable, before the 72th hour following the diagnosis of septic shock
* Mechanical ventilation by tracheal intubation
* Patient sedated with a RASS score inferior or equal to -2
* Age ≥ 18 years
* BMI ≤ 40 kg / m²
* Informed patient having signed the consent
* Effective contraception in women of childbearing age (pregnancy test by B-HCG will be done; for menopausal women, a diagnosis of confirmation must be obtained).
Exclusion Criteria:
* BMI\> 40kg / m²
* Patient reduced by one or two lower limbs
* Rheumatological pathology, trauma or surgery of the lower limbs, pelvis or spine resulting of any limitations of the range of motions or strict immobilization
* Brain-injured patient and / or medulla injured
* Hemodialysis continues with a femoral catheter without possibility of changing the catheter location
* Moribund patient, Stop or Limitation of Active Therapeutics' decision
* Contraindications to standard physical therapy or the cyclo-ergometer
* Untreated orthopedics: deep vein thrombosis of the member concerned
* Dermatological: severe lesions or complex dressings in the sector concerned
* Patient with ExtraCorporeal Membrane Oxygenation (ECMO)
* Pregnant or breastfeeding women
* Patient participating in another trial with the same main objective
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02872792
Study Brief:
Protocol Section:
NCT02872792